Skip to main content
Premium Trial:

Request an Annual Quote

10x Genomics Closes $50M Financing Round, $75M Credit Facility

NEW YORK (GenomeWeb) – 10x Genomics announced today that it has closed a $50 million Series D financing round, as well as a new $75 million credit facility.

The Series D round was led by Meritech Capital Partners, and included new investor Wells Fargo and current investors Paladin Capital, Fidelity, and SoftBank Group. The credit facility is with Silicon Valley Bank.

10x said it will use the proceeds from the transactions for technology development, as well as to invest in strategic opportunities, improve its manufacturing capabilities, and expand its global footprint — including opening new offices in the Netherlands and Shanghai, China.

The Pleasanton, California-based firm makes the Chromium Controller platform, which incorporates linked-read technology for exome and genome sequencing and can also be used for various single-cell analysis applications. It recently previewed three new single-cell assays that it plans to launch this year for the Chromium, including single-cell CNV, single-cell ATAC-seq, and single-cell feature barcoding. 10x launched the single-cell CNV assay just two weeks ago.

Earlier this year, 10x disclosed that it generated $71 million in revenue in 2017, and said it has placed more than 600 of its Chromium instruments worldwide. It also recently announced a partnership with Berry Genomics for noninvasive prenatal testing in China and a deal with BGI subsidiary MGI to make its sequencers compatible with the Chromium system.

The Scan

Less Than Half

An effort to reproduce key findings from high-profile preclinical cancer studies finds less than half could be replicated, according to the Scientist.

Still Some SARS-CoV-2 Sequencing Holes

The Wall Street Journal reports that viral genomic surveillance has improved in the US, though says there are still gaps.

Avoiding Passing Them On

People with known disease-linked genetic variants are turning to in vitro fertilization so as to not pass those variants to their children, the Washington Post says.

PNAS Papers on Long Cell-Free DNA in Maternal Plasma, Genetic Propensity for Voting

In PNAS this week: long, cell-free DNA of maternal and fetal origins identified in maternal plasma, and more.